Vestal Point Capital, LP
68 holdingsFiling period: 2026-06-30Current AUM: $3.83Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | BMRN | BioMarin Pharmaceutical Inc | 6.03M | $344.8M | $333.5M | 8.70% | +2.45M | 2026-06-30 |
| 2 | NBIX | Neurocrine Biosciences Inc | 1.88M | $316.8M | $274.5M | 7.16% | +630.0K | 2026-06-30 |
| 3 | ABVX | Abivax SA | 2.35M | $313.1M | $204.4M | 5.33% | +849.4K | 2026-06-30 |
| 4 | UTHR | United Therapeutics Corp | 435.0K | $235.7M | $257.2M | 6.71% | +360.0K | 2026-06-30 |
| 5 | ELVN | Enliven Therapeutics Inc | 4.00M | $203.0M | $174.8M | 4.56% | +750.0K | 2026-06-30 |
| 6 | NRIX | Nurix Therapeutics Inc | 8.05M | $195.3M | $214.9M | 5.61% | +1.55M | 2026-06-30 |
| 7 | BCAX | Bicara Therapeutics Inc | 5.25M | $155.9M | $91.8M | 2.39% | -175,000 | 2026-06-30 |
| 8 | TSHA | Taysha Gene Therapies Inc | 19.41M | $132.2M | $82.5M | 2.15% | +1.42M | 2026-06-30 |
| 9 | ARWR | Arrowhead Pharmaceuticals Inc | 1.57M | $128.4M | $93.0M | 2.43% | -700,000 | 2026-06-30 |
| 10 | ABT | Abbott Laboratories | 1.40M | $127.0M | $144.3M | 3.77% | -- | 2026-06-30 |
| 11 | ZBH | Zimmer Biomet Holdings Inc | 1.40M | $120.5M | $134.5M | 3.51% | +1.21M | 2026-06-30 |
| 12 | IRON | Disc Medicine Inc | 1.55M | $113.4M | $123.8M | 3.23% | +850.0K | 2026-06-30 |
| 13 | GLUE | Monte Rosa Therapeutics Inc | 4.60M | $111.3M | $49.0M | 1.28% | +996.5K | 2026-06-30 |
| 14 | PODD | Insulet Corp | 670.0K | $102.0M | $100.4M | 2.62% | +619.4K | 2026-06-30 |
| 15 | — | Ascendis Pharma A/S | 375.0K | $100.0M | $100.0M | 2.61% | -- | 2026-06-30 |
| 16 | — | AstraZeneca PLC | 450.0K | $85.3M | $85.3M | 2.23% | +350.0K | 2026-06-30 |
| 17 | SNY | Sanofi SA | 2.00M | $85.3M | $83.8M | 2.19% | +600.0K | 2026-06-30 |
| 18 | RVMD | Revolution Medicines Inc | 450.0K | $84.3M | $83.8M | 2.19% | -1,925,000 | 2026-06-30 |
| 19 | BCRX | BioCryst Pharmaceuticals Inc | 8.30M | $83.0M | $67.2M | 1.75% | +1.27M | 2026-06-30 |
| 20 | DYN | Dyne Therapeutics Inc | 3.38M | $75.0M | $57.2M | 1.49% | -625,000 | 2026-06-30 |
| 21 | NKTR | Nektar Therapeutics | 1.00M | $69.8M | $38.0M | 0.99% | +715.0K | 2026-06-30 |
| 22 | GMED | Globus Medical Inc | 850.0K | $67.2M | $68.8M | 1.79% | +239.5K | 2026-06-30 |
| 23 | TARS | Tarsus Pharmaceuticals Inc | 1.05M | $66.1M | $74.3M | 1.94% | +850.0K | 2026-06-30 |
| 24 | — | Immatics NV | 6.17M | $62.6M | $62.6M | 1.63% | -- | 2026-06-30 |
| 25 | TRVI | Trevi Therapeutics Inc | 3.10M | $57.8M | $41.4M | 1.08% | +933.5K | 2026-06-30 |
← Scroll →
Page 1 of 3